Recent advances and challenges in antibacterial drug development
Valeria Gigante(World Health Organization), Peter Beyer(University of Tampa), Hatim Sati(World Health Organization)
Cited by 41
Related Papers
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
|International Journal of Infectious Diseases|2021|256
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221
Impact of climate change and natural disasters on fungal infections
|The Lancet Microbe|2024|204